Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03189186
Title Phase-I Trial of Pembrolizumab and Percutaneous Cryoablation Combination Followed by Nephron-Sparing Surgery or Cytoreductive Nephrectomy in Locally Advanced and Metastatic Renal Cell Carcinomas
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of California, Irvine
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine Health Department of Urology Orange California 92868 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field